Product Information

BRIMONIDINE 0.2% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.8853 per ML under NDC 24208041105. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on May 28, 2003. Its Orange Book therapeutic-equivalence code is AT.

BRIMONIDINE 0.2% EYE DROP

Brimonidine Tartrate
$0.8853per ML

Strength

2 mg/mL

NDC

24208041105

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076260

FDA Approved

5/28/2003

TE Code

AT

On Market Since

5/28/2003

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE 0.2% EYE DROP has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8853 per ML
All-time high$0.9708 (Nov 13, 2019)
All-time low$0.6907 (May 22, 2024)
52-week high$0.8853
52-week low$0.7695
Median price$0.8051
Average price$0.8172
Largest weekly change+25.0% (Jun 19, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+3.8%

3M

+8.0%

6M

+15.0%

1Y

+12.9%

3Y

+15.0%

5Y

-1.1%

All

-4.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE 0.2% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $0.8853 per ML (NDC 24208041105), effective Nov 11, 2026.

How has the price of BRIMONIDINE 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE 0.2% EYE DROP has declined 4.5%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE 0.2% EYE DROP?

Since Nov 28, 2013, the NADAC for BRIMONIDINE 0.2% EYE DROP has ranged from a low of $0.6907 (May 22, 2024) to a high of $0.9708 (Nov 13, 2019), with a median of $0.8051 per ML.

Are there cheaper alternatives to BRIMONIDINE 0.2% EYE DROP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE 0.2% EYE DROP, is $0.5065 per ML — about 43% below BRIMONIDINE 0.2% EYE DROP.

Who manufactures BRIMONIDINE 0.2% EYE DROP?

BRIMONIDINE 0.2% EYE DROP (NDC 24208041105) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.